May/June 2026
May/June 2026 | Features
Anti-VEGF Step Therapy: An Update
Despite ongoing advocacy efforts, this payer policy persists, putting vision at risk.
Lucas McGuire, BS; Baseer Ahmad, MD; and Jennifer Adeghate, MD, PhD
May/June 2026 | Global Perspectives
A Primer on FAF
Even with the advances in imaging technology, fundus autofluorescence remains integral to our imaging protocols. Here’s why.
Thomas Ach, MD, MSc, FEBO, and Andreas Pollreisz, MD
Popular Articles
April 2026 Insert
One to Watch: Samir N. Patel, MD
Samir N. Patel, MD
March 2026 Insert | One To Watch
One to Watch: Archana A. Nair, MD, MS
Archana A. Nair, MD, MS
March 2026 Supplement | Digital Supplement
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
November/December 2025 Supplement
Preserving Vision in Macular Telangiectasia Type 2
Jay Chhablani, MD, and Lihteh Wu, MD
March 2026 Supplement | Digital Supplement
From Vascular Curiosity to Neurodegenerative Disease: A Consensus Statement for the Diagnosis and Management of Macular Telangiectasia Type 2
Lejla Vajzovic, MD, FASRS; Sophie Bakri, MD; W. Lloyd Clark, MD; Diana Do, MD; Dean Eliott, MD; Roger Goldberg, MD; and Dante Pieramici, MD